rTMS as a Treatment of Neuropathic Pain Secondary to Malignancy
Repetitive Transcranial Magnetic Stimulation in Neuropathic Pain Secondary to Malignancy.
1 other identifier
interventional
34
0 countries
N/A
Brief Summary
The purpose of this study isto assess the efficacy of daily 10 sessions of rTMS over primary motor cortex in patients suffering from malignant neuropathic pain. Thirty four patients were divided randomly into 2 groups equally using closed envelops to undergo real (20 Hz, 10 second, 10 trains with inter-train interval 30 second with total pulses 2000, intensity 80% of motor threshold over hand area of motor cortex) or sham rTMS (same parameters but with coil elevated and angled away from the head)every day for ten consecutive days (5 days/week). Patients were evaluated using a verbal descriptor scale (VDS), visual analog scale (VAS), Leeds assessment of neuropathic symptoms and signs (LANSS) and Hamilton rating scale for depression (HAM-D) at baseline, after 1st, 5th, 10thtreatment session, and then 15 days and 1 month after the end of treatment. ic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2010
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 1, 2014
CompletedFirst Posted
Study publicly available on registry
March 5, 2014
CompletedMarch 5, 2014
February 1, 2014
3.3 years
March 1, 2014
March 1, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neuropathic pain improvement
Reduction of neuropathic pain in patients with malignancy measured by VDS, VAS, LANSS.
one month
Secondary Outcomes (1)
Reduction of depression manifestation
one month
Study Arms (2)
Real rTMS
ACTIVE COMPARATORThe active group received Real rTMS over the hand area of motor cortex (20 Hz, 10 second, 10 trains with inter-train interval 30 second with total pulses 2000, intensity 80% of motor threshold) every day for ten consecutive days (5 days/week).
Sham rTMS
SHAM COMPARATORSham-rTMS was applied using the same parameters but with the coil elevated and angled away from the head to reproduce the same of subjective sensation of rTMS
Interventions
Eligibility Criteria
You may qualify if:
- All patients within age group 18-65 years with malignant lateralized neuropathic pain resistant to medical treatment for at least 2 months or associated with significant adverse effects from medication were involved in this study.
You may not qualify if:
- Patients with intracranial metallic devices Patients with pacemakers or any other device. Patients with recent myocardial ischemia, unstable angina Patients known to have history of epilepsy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
March 1, 2014
First Posted
March 5, 2014
Study Start
January 1, 2010
Primary Completion
May 1, 2013
Study Completion
May 1, 2013
Last Updated
March 5, 2014
Record last verified: 2014-02